These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15511665)

  • 1. Cellular mechanisms of T cell mediated drug hypersensitivity.
    Gerber BO; Pichler WJ
    Curr Opin Immunol; 2004 Dec; 16(6):732-7. PubMed ID: 15511665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed drug hypersensitivity reactions - new concepts.
    Posadas SJ; Pichler WJ
    Clin Exp Allergy; 2007 Jul; 37(7):989-99. PubMed ID: 17581192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological interaction of drugs with immune receptors: the p-i concept.
    Pichler WJ; Beeler A; Keller M; Lerch M; Posadas S; Schmid D; Spanou Z; Zawodniak A; Gerber B
    Allergol Int; 2006 Mar; 55(1):17-25. PubMed ID: 17075282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting drug hypersensitivity by in vitro tests.
    Pichler WJ
    ALTEX; 2007; 24 Spec No():49-52. PubMed ID: 19835057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug hypersensitivity reactions: pathomechanism and clinical symptoms.
    Pichler WJ; Adam J; Daubner B; Gentinetta T; Keller M; Yerly D
    Med Clin North Am; 2010 Jul; 94(4):645-64, xv. PubMed ID: 20609855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfection of drug-specific T-cell receptors into hybridoma cells: tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds.
    Schmid DA; Depta JP; Lüthi M; Pichler WJ
    Mol Pharmacol; 2006 Jul; 70(1):356-65. PubMed ID: 16617162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
    Schmid DA; Depta JP; Pichler WJ
    Clin Exp Allergy; 2006 Jan; 36(1):59-69. PubMed ID: 16393267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune mechanism of drug hypersensitivity.
    Pichler WJ
    Immunol Allergy Clin North Am; 2004 Aug; 24(3):373-97, v-vi. PubMed ID: 15242717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the T-cell response in a patient with phenindione hypersensitivity.
    Naisbitt DJ; Farrell J; Chamberlain PJ; Hopkins JE; Berry NG; Pirmohamed M; Park BK
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1058-65. PubMed ID: 15743920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of drug allergy--current concepts and recent insights.
    Schnyder B; Brockow K
    Clin Exp Allergy; 2015 Sep; 45(9):1376-83. PubMed ID: 26172398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-immune response relationships of hapten-modified collagen II peptides in a T-cell model of allergic contact dermatitis.
    Holmdahl M; Ahlfors SR; Holmdahl R; Hansson C
    Chem Res Toxicol; 2008 Aug; 21(8):1514-23. PubMed ID: 18616296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suboptimal recognition of a T cell epitope of the major dog allergen Can f 1 by human T cells.
    Juntunen R; Liukko A; Taivainen A; Närvänen A; Durand G; Kauppinen A; Nieminen A; Rytkönen-Nissinen M; Saarelainen S; Maillère B; Virtanen T; Kinnunen T
    Mol Immunol; 2009 Oct; 46(16):3320-7. PubMed ID: 19700193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell receptor (TCR) interaction with haptens: metal ions as non-classical haptens.
    Thierse HJ; Gamerdinger K; Junkes C; Guerreiro N; Weltzien HU
    Toxicology; 2005 Apr; 209(2):101-7. PubMed ID: 15767020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell response in penicillin allergy.
    Padovan E
    Clin Exp Allergy; 1998 Sep; 28 Suppl 4():33-6. PubMed ID: 9761028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro tests in drug hypersensitivity diagnosis.
    Lochmatter P; Zawodniak A; Pichler WJ
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):537-54. PubMed ID: 19563996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development.
    Ford MS; Chen W; Wong S; Li C; Vanama R; Elford AR; Asa SL; Ohashi PS; Zhang L
    Eur J Immunol; 2007 Aug; 37(8):2234-41. PubMed ID: 17578845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides.
    Ulivieri C; Citro A; Ivaldi F; Mascolo D; Ghittoni R; Fanigliulo D; Manca F; Baldari CT; Li Pira G; Del Pozzo G
    Immunol Lett; 2008 Aug; 119(1-2):62-70. PubMed ID: 18538862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and quantification of drug-specific T cells in penicillin allergy.
    Rozieres A; Hennino A; Rodet K; Gutowski MC; Gunera-Saad N; Berard F; Cozon G; Bienvenu J; Nicolas JF
    Allergy; 2009 Apr; 64(4):534-42. PubMed ID: 19154548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic diversity in delayed drug hypersensitivity: an immunologic explanation.
    Meth MJ; Sperber KE
    Mt Sinai J Med; 2006 Sep; 73(5):769-76. PubMed ID: 17008937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct T-cell stimulations by drugs--bypassing the innate immune system.
    Pichler WJ
    Toxicology; 2005 Apr; 209(2):95-100. PubMed ID: 15767019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.